Skip to main content
Katherine Fuh, MD, Obstetrics & Gynecology, San Francisco, CA

Katherine Fuh MD PhD

Gynecologic Oncology


Washington University, Gynecologic Oncology

Join to View Full Profile
  • 1825 4th StFl 6San Francisco, CA 94143

  • Phone+1 415-353-9600

  • Fax+1 415-353-7657

Dr. Fuh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Gynecologic Oncology, 2009 - 2012
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 2005 - 2009
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2005

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2026
  • MO State Medical License
    MO State Medical License 2013 - 2024
  • IL State Medical License
    IL State Medical License 2022 - 2023
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Gynecologic Oncology
    American Board of Obstetrics and Gynecology Gynecologic Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer  
    Ian S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
  • Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer  
    Ian S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research

Lectures

  • Identifying a potential biomarker for anti-PD-1 immunotherapy in patients with advanced stage, surgically-resectable endometrial cancer. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Endometrial Cancer: Molecular Classification, Genetics, When to Rebiopsy, and What's New in the Research
    Endometrial Cancer: Molecular Classification, Genetics, When to Rebiopsy, and What's New in the ResearchMarch 12th, 2025
  • SGO Ways to Wellness: An Open Letter to My Former Self
    SGO Ways to Wellness: An Open Letter to My Former SelfJanuary 6th, 2025
  • Aravive to Host Virtual KOL Event on Its Late-Stage Oncology Asset Batiraxcept
    Aravive to Host Virtual KOL Event on Its Late-Stage Oncology Asset BatiraxceptMay 8th, 2023
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: